Opportunity Information: Apply for RFA MD 15 009
Apply for RFA MD 15 009
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Innovations for Healthy Living Improving Population Health and Eliminating Health Disparities (R43)/(R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.307 Minority Health and Health Disparities Research.
- This funding opportunity was created on Apr 24, 2015 and posted on Apr 24, 2015.
- Applicants must submit their applications by Jul 23, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: Small businesses.
- Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Innovations for Healthy Living: Improving Population Health and Eliminating Health Disparities (R43)/(R44)" is a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) funding announcement that supports U.S. small businesses working on practical, commercialization-ready innovations aimed at improving population health and reducing health disparities. The core intent is to move beyond research for its own sake and instead accelerate the development of a tangible product, process, or service that can be brought to market and used in real-world settings to prevent disease, improve health, and narrow gaps in both healthcare access and health outcomes. The FOA emphasizes solutions that are not only scientifically sound, but also realistic to deploy and sustain where disparities are most pronounced.
A central theme of this opportunity is equity-focused innovation. NIH is looking for technologies or approaches that are effective, affordable, culturally acceptable, and deliverable to groups that experience persistent disadvantages in health and healthcare. The announcement specifically highlights racial and ethnic minority populations, low-income communities, and rural populations as priority beneficiaries. In practical terms, applicants are expected to demonstrate that the proposed innovation is designed with these communities in mind, including how it will be adopted, used, and maintained in settings that may face resource constraints, workforce shortages, transportation barriers, language and cultural mismatches, or limited broadband and infrastructure.
This FOA uses the SBIR grant mechanisms R43 and R44, which correspond to Phase I and Phase II of the SBIR program. Phase I (R43) typically supports early-stage feasibility work, such as proof-of-concept development, initial prototyping, and preliminary testing to show that the idea can work and is worth scaling. Phase II (R44) generally supports more advanced research and development, such as refinement of the technology, validation in relevant settings, preparation for regulatory or implementation pathways when applicable, and other steps needed to reach commercialization. Because the FOA explicitly frames the goal as commercialization, competitive applications generally need to show not only technical merit but also a credible path to market and to meaningful impact on health disparities once the innovation is deployed.
The program sits within NIH's health-related funding portfolio and is associated with CFDA number 93.307, "Minority Health and Health Disparities Research." The total estimated funding listed for this announcement is $1,000,000, with an expectation of about four awards. The funding instrument is a grant, the opportunity category is discretionary, and there is no cost-sharing or matching requirement, meaning applicants are not required to contribute matching funds as a condition of award.
Eligibility is limited to eligible United States small business concerns. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible to apply. However, "foreign components" as defined under the NIH Grants Policy Statement may be allowable in some cases, which typically means that certain elements of the project could involve foreign work if appropriately justified and permitted under NIH policy, though the applicant organization itself must be a qualifying U.S. small business.
Key administrative details in the source information include the Funding Opportunity Number RFA-MD-15-009, with the original posting date of April 24, 2015. The closing date for applications was July 23, 2015, and the opportunity was archived on August 23, 2015. The administering agency is the National Institutes of Health. An additional information link was provided through the NIH grants guide (http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-15-009.html). For access or technical issues with the online announcement, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV, including support for both difficulty accessing the full announcement and problems linking to it.
Overall, this FOA targets small businesses that can translate innovation into real, deployable solutions that measurably improve health and reduce inequities. Strong alignment with the FOA means demonstrating not just a novel idea, but a practical and culturally informed implementation and commercialization approach that reaches underserved communities and improves outcomes in a way that can scale.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled "Innovations for Healthy Living: Improving Population Health and Eliminating Health Disparities (R43)/(R44)."
Which agency is offering this funding opportunity?
The administering agency is the National Institutes of Health (NIH).
What type of funding program is this?
This is an NIH Small Business Innovation Research (SBIR) funding opportunity using the R43 (Phase I) and R44 (Phase II) grant mechanisms.
What is the main purpose of this SBIR FOA?
The core intent is to support U.S. small businesses developing practical, commercialization-ready innovations that improve population health and reduce health disparities. The focus is on moving beyond research alone and accelerating a product, process, or service that can be deployed in real-world settings.
What kinds of outcomes is NIH looking for from funded projects?
The FOA emphasizes tangible innovations that can be brought to market and used to prevent disease, improve health, and narrow gaps in healthcare access and health outcomes. Solutions are expected to be scientifically sound and realistic to deploy and sustain where disparities are most pronounced.
What does "equity-focused innovation" mean in the context of this opportunity?
It means proposing technologies or approaches that are effective, affordable, culturally acceptable, and deliverable to groups that experience persistent disadvantages in health and healthcare. Applicants are expected to show that the innovation is designed with these communities in mind and can be adopted and maintained in resource-constrained settings.
Which populations are specifically highlighted as priority beneficiaries?
The announcement specifically highlights racial and ethnic minority populations, low-income communities, and rural populations.
What real-world barriers should applicants consider when designing solutions?
The FOA notes that priority settings may face resource constraints, workforce shortages, transportation barriers, language and cultural mismatches, and limited broadband and infrastructure. Applicants are expected to address how the innovation will be adopted, used, and maintained given these realities.
What do the R43 and R44 mechanisms correspond to?
R43 corresponds to SBIR Phase I, and R44 corresponds to SBIR Phase II.
What is typically supported in Phase I (R43)?
Phase I (R43) typically supports early-stage feasibility work such as proof-of-concept development, initial prototyping, and preliminary testing to demonstrate the idea can work and is worth scaling.
What is typically supported in Phase II (R44)?
Phase II (R44) generally supports more advanced R&D such as refining the technology, validating it in relevant settings, preparing for regulatory or implementation pathways when applicable, and other steps needed to reach commercialization.
How important is commercialization for this FOA?
Commercialization is a central goal. Competitive applications generally need to show both technical merit and a credible path to market, along with a clear plan for meaningful impact on health disparities once deployed.
What is the CFDA number associated with this opportunity?
The program is associated with CFDA number 93.307, "Minority Health and Health Disparities Research."
What is the total estimated funding amount and expected number of awards?
The total estimated funding is $1,000,000, with an expectation of about four awards.
What is the funding instrument and opportunity category?
The funding instrument is a grant, and the opportunity category is discretionary.
Is cost sharing or matching required?
No. There is no cost-sharing or matching requirement for this opportunity.
Who is eligible to apply?
Eligibility is limited to eligible United States small business concerns.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible to apply.
Are non-U.S. components of U.S. organizations eligible to apply?
No. Non-U.S. components of U.S. organizations are also not eligible to apply.
Are any foreign activities allowed under this FOA?
Foreign components (as defined under the NIH Grants Policy Statement) may be allowable in some cases, typically meaning certain elements of a project could involve foreign work if appropriately justified and permitted under NIH policy. The applicant organization itself must still be a qualifying U.S. small business.
What is the Funding Opportunity Number?
The Funding Opportunity Number is RFA-MD-15-009.
When was this opportunity originally posted?
The original posting date was April 24, 2015.
What was the application closing date?
The closing date for applications was July 23, 2015.
Is this opportunity still open?
No. The opportunity was archived on August 23, 2015.
Where can I find the official NIH grants guide link for this FOA?
The additional information link provided is http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-15-009.html.
Who should be contacted for access or technical issues with the online announcement?
For difficulty accessing the full announcement or problems linking to it, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Health
Next opportunity: Tri colored Bat Cave Hibernacula and Roost Tree Management in Great Smoky Mountains National Park
Previous opportunity: NIH PEPFAR Collaboration on Implementation Science for HIV Towards an AIDS free Generation (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MD 15 009
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MD 15 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| Technologies for Improving Population Health and Eliminating Health Disparities (R41/R42) Apply for RFA MD 15 008 Funding Number: RFA MD 15 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| PPHF 2015 REACH Racial and Ethnic Approaches to Community Health (REACH) financed in part by 2015 Prevention and Public Health Funding Apply for CDC RFA DP14 141902PPHF15 Funding Number: CDC RFA DP14 141902PPHF15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Leader Fellowship Program Apply for CDC RFA PS15 1508 Funding Number: CDC RFA PS15 1508 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Dissemination of Evidence Informed Interventions to Improve Health Outcomes along the HIV Care Continuum Implementation Technical Assistance Center Apply for HRSA 15 130 Funding Number: HRSA 15 130 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Dissemination of Evidence Informed Interventions to Improve Health Outcomes along the HIV Care Continuum Dissemination and Evaluation Center Apply for HRSA 15 030 Funding Number: HRSA 15 030 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Analyses of Human Datasets and Biospecimens to Characterize Aging related Phenotypes Relationships to Circulating Polypeptides and Proteins that Reverse or Accelerate Aging Changes (R01) Apply for RFA AG 16 012 Funding Number: RFA AG 16 012 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| T1 Translational Research Novel Interventions for Prevention and Treatment of Age related Conditions (R21) Apply for PAR 15 190 Funding Number: PAR 15 190 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Consortia for Innovative AIDS Research in Nonhuman Primates (UM1) Apply for RFA AI 15 022 Funding Number: RFA AI 15 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Infrastructure Resource Access (X01) Apply for PAR 15 195 Funding Number: PAR 15 195 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| T2 Translational Research Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21) Apply for PAR 15 191 Funding Number: PAR 15 191 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R01) Apply for PAR 15 192 Funding Number: PAR 15 192 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R21) Apply for PAR 15 193 Funding Number: PAR 15 193 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| PPHF 2015 Asian Language Tobacco Quitline financed solely by 2015 Prevention and Public Health Funds Apply for CDC RFA DP15 1503 Funding Number: CDC RFA DP15 1503 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| World Health Organization Addressing Ebola and other Highly Infectious Diseases Internationally Apply for CDC RFA CK15 1505 Funding Number: CDC RFA CK15 1505 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Telehealth Focused Rural Health Research Center Cooperative Agreement Apply for HRSA 15 149 Funding Number: HRSA 15 149 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Small Business Innovation in Clinical Trials Direct to Phase II (U44) Apply for PAR 15 194 Funding Number: PAR 15 194 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Community Sanitation and Nutritional Status in Key Vulnerable Areas in Laos Apply for AID 486 15 000002 Funding Number: AID 486 15 000002 Agency: Thailand USAID Bangkok Category: Health Funding Amount: $5,600,000 |
| Developmental AIDS Research Center on Mental Health and HIV/AIDs (P30) Apply for PAR 15 196 Funding Number: PAR 15 196 Agency: National Institutes of Health Category: Health Funding Amount: $550,000 |
| AIDS Research Center on Mental Health and HIV/AID (P30) Apply for PAR 15 197 Funding Number: PAR 15 197 Agency: National Institutes of Health Category: Health Funding Amount: $1,100,000 |
| Improving Adult Immunization Rates through Partnerships with Providers and National Organizations Apply for CDC RFA IP15 1503 Funding Number: CDC RFA IP15 1503 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MD 15 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.